Sanofi Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Sanofi for the month of June 2018. The filing serves to incorporate by reference a press release dated June 19, 2018, regarding a significant executive appointment.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose a corporate governance event rather than a financial results report.
Material Changes
The primary material change disclosed is the appointment of Jean-Baptiste Chasseloup de Chatillon as Executive Vice President and Chief Financial Officer.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on performance, or discussion of risks and contingencies. The content is limited to the announcement of the new CFO.
Key Facts for Investor Verification
- Sanofi appointed Jean-Baptiste Chasseloup de Chatillon as Executive Vice President and Chief Financial Officer.
- The appointment was announced via press release on June 19, 2018.
- The filing was signed on June 20, 2018, by Alexandra Roger, Head of Securities Law and Capital Markets.
- No financial performance data is included in this specific filing.